ClinicalTrials.gg
Enrolling by invitationNCT06667102SISIUpdated Oct 31, 2024

Strategic and Interactive Signing Instruction

An interventional study of Strategic and Interactive Signing Instruction in Teaching Behaviors and Sign Language Skills, sponsored by The University of Tennessee, Knoxville. Enrolling by invitation at 1 site in United States. Open to participants aged 4 Years to 99 Years. Per ClinicalTrials.gov, last updated 2024-10-31.

Sponsored by The University of Tennessee, Knoxville · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as enrolling by invitation.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
4 Years to 99 Years
Sex
All
01

Study summary

Strategic and interactive approaches driven by sociocultural, cognitive, and language theories have accumulated a large body of evidence documenting improvements in more complex oral and written language skills. Growing evidence demonstrates that more complex sign language skills positively predict literacy skills and may lead to improved health outcomes. This project involves new applications of theory-driven strategic and interactive approaches in an intervention program to target sign language development in deaf children between 5 and 8 years old who are at high risk of language delays.

Read the detailed description

Deaf children who reach the age of eight without a foundation in language have longitudinal struggles in the areas of receptive and expressive language, working memory, executive functions, literacy and academic skills, and behavioral, mental, social, and physical health. The lack of intervention programs targeting sign language competencies during the critical period of development is a critical barrier to making progress in preventing or addressing language delays in deaf children. Strategic and interactive approaches driven by sociocultural, cognitive, and language theories have accumulated a large body of evidence documenting improvements in more complex oral and written language skills. Cross-linguistic transfers between oral and writing skills within and across first and second languages are well-established in the literature. Taking these factors into account in addition to growing evidence that sign language skills positively predict literacy skills and may lead to improved health outcomes, it is critical to systematically support deaf children's sign language competences as early as possible. To address the identified critical barrier to progress, these are the aims of this project: (1) develop Strategic and Interactive Signing Instruction (SISI), an intervention program to target the development of sign language skills in deaf children aged 5-8; (2) refine SISI training and implementation protocols; and (3) test the efficacy of SISI in improving deaf children's sign language skills. First, a SISI manual will be developed for standardization and consistency in training, implementation, and fidelity. The SISI manual will include: (a) descriptions of strategic and interactive approaches and their new applications to develop sign language skills, (b) SISI intervention protocols, (c) SISI fidelity checklist, and (d) list of sign language skills that are targeted in SISI. Second, an experimental study will be conducted to assess the extent of training and support required from teachers to become proficient in SISI implementation. Meanwhile, child progress in meeting their target sign language skills will be monitored formatively, and modifications may be made in an iterative design fashion to strengthen the intervention design. Third, another experimental study will be applied to assess the efficacy of SISI in improving deaf children's sign language skills. Findings will provide robust data on the mechanisms of successful training dose, intervention design and fidelity, and data collection protocols in preparation for subsequent R01 application involving a large randomized controlled trial with sufficient statistical power to further strengthen evidence of SISI in improving deaf children's sign language skills along with examinations of cross-linguistic interactions in the written form. This project is innovative in its new applications of theory-driven strategic and interactive approaches to target sign language development in deaf children.

02

Conditions studied

  • Teaching Behaviors
  • Sign Language Skills

Keywords

  • Sign language
  • Teacher training
  • Language deprivation
03

In context

Lead sponsor

The University of Tennessee, Knoxville is the lead sponsor of 95 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Deaf students in prekindergarten to 3rd grade classes
  • Teachers of the deaf in prekindergarten to 3rd grade classes

Exclusion criteria

Exclusion Criteria:

  • Hearing students, deaf students aged 0-3 or 4th grade and beyond
  • Non-teachers of the deaf or teachers of the deaf in 4th grade and beyond
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    Improving Teacher Fidelity to SISI

    A noncurrent multiple baseline design across teacher participants will be utilized to assess the extent of support required by teachers to become proficient in SISI implementation. In this study, the independent variable is the SISI training, and the dependent variable is teacher fidelity to the SISI program as measured by the SISI fidelity checklist.

    Behavioral: Strategic and Interactive Signing Instruction

  • Experimental
    Control and Experimental Groups: SISI Efficacy

    This pre- and post- study provides baseline data on deaf children's sign language development prior to receiving SISI. Additionally, each participating teacher will submit a recorded instructional unit showcasing their best methods for supporting sign language development. This provides a further layer of baseline analysis, allowing the PI to assess the instructional methods already in use prior to SISI professional development and implementation. Demographic data for both teachers and students will also be collected in preparation for the quasi-experiment study. Then, teachers will be assigned to either an experimental group, which will receive SISI professional development, or a control group that will continue with their usual teaching practices. In this quasi-experiment study, SISI's efficacy will be evaluated by comparing outcomes between the two groups.

    Behavioral: Strategic and Interactive Signing Instruction

  • Experimental
    Pre- and Post- Descriptive Study Data of Language Outcomes Children

    Up to 40 children from 4 classes will provide pre- and post-data in which they respond to a prompt in sign language on video.

    Behavioral: Strategic and Interactive Signing Instruction

  • Experimental
    Single Case Research Design: Deaf Children's Language Growth

    Single case research design will provide robust day-to-day data of causal relations between SISI and sign language skills. Given teachers' high fidelity in SISI implementation, a noncurrent multiple baseline design across child participants will be applied to assess the extent of SISI improving deaf children's target sign language skills in a year. The independent variable of this study is the SISI implementation, which is used to improve the dependent variables which will be target sign language skills.

    Behavioral: Strategic and Interactive Signing Instruction

Interventions

  • BehavioralStrategic and Interactive Signing Instruction

    SISI centers on deaf children producing sign language compositions to communicate their messages with identified audiences, and teachers utilizing strategic and interactive approaches to bring attention to target sign language skills by consciously monitoring and manipulating language to create desired meanings grounded in socially shared understandings.

06

What researchers measure

Primary outcomes

  1. Sign Language Skills

    Deaf children's application of genre-based trait skills in sign language will be analyzed using rubrics adapted from the National Assessment of Educational Progress (NAEP) rubrics for standardized writing assessments.

    Time frame: From enrollment to the end of treatment 9 academic months later.

  2. Teaching Behaviors

    Teachers' fidelity to SISI will be measured through the fidelity instrument.

    Time frame: From enrollment to the end of treatment 9 academic months later.

Secondary outcomes

  1. Written Language

    Deaf children's application of genre-based trait skills in written language will be analyzed using the emergent writing stages and rubrics adapted from the National Assessment of Educational Progress (NAEP) rubrics for standardized writing assessments.

    Time frame: From enrollment to the end of treatment 9 academic months later.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — The data from interventions in all four arms (two single case research designs and two baseline / quasi-experimental designs) will be shared in .csv files.

Supporting information: Clinical study report

Time frame: IPD will be made available on 12/30/2026 with no end date.

Access criteria: A researcher may access the IPD by contacting the principal investigator.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Aug 2024 (actual). Primary completion is estimated for Jun 2026, 22 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 29, 2024
First posted
Oct 31, 2024
StartActual
Aug 23, 2024
Primary completionEst.
Jun 30, 2026
CompletionEst.
Dec 30, 2026
Last update
Oct 31, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 31, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06667102
Lead sponsor
The University of Tennessee, Knoxville
Responsible party
Sponsor
First posted
Oct 31, 2024
Start date
Aug 23, 2024
Primary completion
Jun 30, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Oct 31, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion